SELLAS Life Sciences Group, Inc.SLSNASDAQ

Revenue (LTM)

Net Income (LTM)

$-27M

+13.0% YoY

Free Cash Flow

$-28M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	8	1↓86.8%	0	0	0
Gross Profit	7	1↓87.8%	0	0	0
Operating Income	-25	-42↓65.8%	-38↑9.7%	-32↑16.8%	-28↑10.3%
Net Income	-21	-41↓99.5%	-37↑9.6%	-31↑17.3%	-27↑13.0%
EBITDA	-18	-31↓71.9%	1↑101.7%	1↑19.5%	-28↓4573.7%
EPS Diluted	-1.34	-2.13↓59.0%	-1.34↑37.1%	-0.50↑62.7%	-0.25↑50.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	21	17↓20.2%	3↓85.2%	14↑448.9%	72↑417.7%
Total Current Assets	23	18↓22.9%	3↓82.1%	16↑414.7%	75↑360.7%
Total Assets	26	21↓20.8%	6↓70.3%	19↑212.5%	78↑303.2%
Total Current Liabilities	5	16↑211.4%	14↓11.5%	10↓30.8%	7↓26.2%
Total Liabilities	6	16↑164.7%	14↓11.8%	10↓29.8%	7↓25.0%
Total Equity	20	5↓76.2%	-8↓264.4%	9↑218.7%	71↑648.8%
Total Debt	1	1↑17.0%	1↓4.1%	1↑10.5%	1↓0.0%
Net Debt	-21	-16↑21.6%	-2↑90.0%	-13↓693.4%	-71↓450.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-26	-24↑8.5%	-31↓31.9%	-35↓12.7%	-28↑19.8%
Capital Expenditure	0	-5	-6↓22.2%	0	0
Free Cash Flow	-26	-28↓8.8%	-37↓30.4%	-35↑4.1%	-28↑19.8%
Stock-Based Comp	1	2↑70.7%	1↓19.5%	2↑12.5%	2↑25.1%
Net Change in Cash	-14	-4↑69.7%	-15↓245.0%	11↑177.8%	58↑409.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance